Stockreport

Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site [Yahoo! Finance]

Kiromic BioPharma, Inc.  (KRBP) 
PDF has been activated as the fourth clinical trial site in the Deltacel-01 Phase 1 trial evaluating Deltacel ™ (KB-GDT-01), Kiromic's allogeneic, off-the-shelf, Gamma Delta [Read more]